Prospective evaluation of natriuretic peptide based referral of chronic heart failure patients in primary care (PREFER): a pragmatic real world intervention study

27 May 2019 (16:30 - 16:40)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Professor Finn Gustafsson

Pleasanton (United States of America)

10 More presentations in this session

Presentation thumbnail

Discussion - PREFER.

Presentation thumbnail

Sacubitril/valsartan eligibility and outcomes in the ESC HFA EORP Heart Failure Long-Term Registry: bridging between the PARADIGM-HF trial, ESC Guidelines and real-world

Doctor C. Kapelios (Athens, GR)

Presentation thumbnail

Discussion - PARADIGM-HF.

Presentation thumbnail

Clinical presentation, management and 6-month outcome of women diagnosed with PPCM from Europe, Africa, Asia Pacific and Middle East

Professor K. Sliwa (Cape Town, ZA)

Presentation thumbnail

Discussion - Clinical presentation, management and 6-month outcome of women diagnosed with PPCM from Europe, Africa, Asia Pacific and Middle East.

Access the full session

Session thumbnail

Late breaking trial IV - Registries

The Event

Heart Failure 2019

27 May 2019 16:30 CET

You may be interested in

Congress Presentation

The impact of natriuretic peptide testing on heart failure clinic referral

1 July 2021

Congress Session

Optimising the interface between primary and secondary care: from acute to chronic management

27 August 2023

Congress Session

Bridging gaps in heart failure care: primary care trends, exercise, kidney function, and global health perspectives

19 May 2025

Congress Presentation

Determinants of and association with outcomes of referral to specialty vs. primary care in patients with heart failure: data from the Swedish Heart Failure registry

29 June 2021

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources